2019, Number 2
<< Back Next >>
Rev Cent Dermatol Pascua 2019; 28 (2)
Disseminated granuloma annulare
Trejo AJR, González GM, Figueroa BE, Marín RD
Language: Spanish
References: 23
Page: 65-70
PDF size: 338.44 Kb.
ABSTRACT
Granuloma annulare is a noninfectious, benign, self-limited
inflammatory disease of unknown etiology, characterized by
nodular lesions with aspect of shaped annular plates configuration.
Predominates in women, the clinical picture is usually characteristic;
however histopathological study is necessary to confirm the diagnosis.
There is no specific treatment. In this article we present the case of
disseminated granuloma annulare.
REFERENCES
Torres LV, Camacho F, Mihm M, González S, Jurado F, Sánchez- Carpinter I. Dermatología práctica Ibero-Latinoamericana. 2a edición. México: Encuentros Científicos Académicos S.C.; 2012. pp. 56.1-56.6.
Smith MD, Downie JB, DiCostanzo D. Granuloma annulare. Int J Dermatol. 1997; 36: 326-333.
Bolognia J, Jorizzo J, Schaffer J. Dermatology. 2nd edition. Elsevier; 2012. Cap. 92: pp. 1426-1428.
Rosti G, Araujo J, Demergasso D, Fernández-Salafia MJ, Chapo R, Mortera M et al. Granuloma anular generalizado: reporte de un caso clínico en respuesta a la dapsona. Arch Argent Dermatol. 2013; 63: 103-107.
Suárez O, Pérez-Pérez L, Pereiro MM, Peteiro-García C, Toribio J. Granuloma anular diseminado localizado en zonas fotoexpuestas. Actas Dermosifiliogr. 2006; 97: 448-450.
Setoyama M, Kerdel FA, Byrnes JJ, Kanzaki T. Granuloma annulare associated with Hodgkin’s disease. Int J Dermatol. 1997; 36: 445-448.
Shimizu S, Yasui C, Tsuchiya K. Atypical generalized granuloma annulare associated with two visceral cancers. J Am Acad Dermatol. 2006; 54: S236-S238.
Narváez V, Vega ME, Sáez MM, Castillo M, Domínguez L. Granuloma anular en pacientes pediátricos. Dermatol Pediatr Lat. 2005; 3: 117-122.
Cassone G, Tumiati B. Granuloma annulare as a possible new adverse effect of topiramate. Int J Dermatol. 2014; 53: 259-261.
Koutroumpas A, Zafiriou E, Terzis A, Sakkas L. Granuloma annulare after infliximab treatment for rheumatoid arthritis. Hellenic Rheumatol. 2008; 20: 103-105.
Wu W, Robinson-Bostom L, Kokkotou E, Jung HY, Kroumpouzos G. Dyslipidemia in granuloma annulare: a case-control study. Arch Dermatol. 2012; 148: 1131-1136.
López L, Ramos GA, Jaidar MA. Granuloma anular diseminado con fenómeno de iatrotopismo. Comunicación de un caso. Rev Cent Dermatol Pascua. 2007; 16: 76-79.
Thornsberry LA, English JC 3rd. Etiology, diagnosis, and therapeutic management of granuloma annulare: an update. Am J Clin Dermatol. 2013; 14: 279-290.
Veraldi S, Bencini PL, Drudi E, Caputo R. Laboratory abnormalities in granuloma annulare: a case-control study. Br J Dermatol. 1997; 136: 652-653.
Lever W, Gundula S. Histopatología de la piel. 7a ed. Philadelphia: Lippincott-Raven Publisher; 1990. pp. 243-246.
Garg S, Baveja S. Generalized granuloma annulare treated with monthly rifampicin, ofloxacin, and minocycline combination therapy. Indian J Dermatol. 2013; 58: 197-199.
Min MS, Lebwohl M. Treatment of recalcitrant granuloma annulare (GA) with adalimumab: A single-center, observational study. J Am Acad Dermatol. 2016; 74: 127-133.
Mahmood T, Mansouri B, Menter A. Successful treatment of generalized granuloma annulare with adalimumab. Clin Exp Dermatol. 2015; 40: 537-539.
Verne SH, Kennedy J, Falto-Aizpurua LA, Griffith RD, Nouri K. Laser treatment of granuloma annulare: a review. Int J Dermatol. 2016; 55: 376-381.
Bronfenbrener R, Ragi J, Milgraum S. Granuloma annulare treated with excimer laser. J Clin Aesthet Dermatol. 2012; 5: 43-45.
Martín-Sáez E, Fernández-Guarino M, Carrillo-Gijón R, Muñoz- Zato E, Jaén-Olasolo P. Efficacy of dapsone in disseminated granuloma annulare: a case report and review of the literature. Actas Dermosifiliogr. 2008; 99: 64-68.
Inui S, Nishida Y, Itami S, Katayama I. Disseminated granuloma annulare responsive to narrowband ultraviolet B therapy. J Am Acad Dermatol. 2005; 53: 533-534.
Buendía-Eisman A, Ruiz-Villaverde R, Blasco-Melguizo J, Serrano- Ortega S. Generalized annular granuloma: response to isotretinoin. Int J Dermatol. 2003; 42: 321-322.